Hematologic malignancies burden in China compared with the United States 1990-2021 and projections to 2040.

Discov Oncol · 2026 · PMC13323456 · PMID 42101532

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Conclusions While the ASIR of hematologic malignancies has risen over recent decades, the ASDR and ASDALYR have showed a decreasing trend, reflecting China’s efforts in reducing the burden of these diseases.

also in 47,180 other papers

an increasing trendno p-value reported

For leukemia, AML, CML, CLL, NHL, MM, and HL, the ASIR, ASDR, and ASDALYR showed an increasing trend with advancing age (Figs. 3 and S3-S7).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.